The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Carbapenem-resistant Enterobacteriaceae Testing Market Research Report 2025
Synopsis
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii.
The global Carbapenem-resistant Enterobacteriaceae Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Carbapenem-resistant Enterobacteriaceae Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Carbapenem-resistant Enterobacteriaceae Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Carbapenem-resistant Enterobacteriaceae Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Carbapenem-resistant Enterobacteriaceae Testing include TBA, SolGent, ELITechGroup, ALIFAX and BioMérieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carbapenem-resistant Enterobacteriaceae Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem-resistant Enterobacteriaceae Testing.
Report Scope
The Carbapenem-resistant Enterobacteriaceae Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carbapenem-resistant Enterobacteriaceae Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbapenem-resistant Enterobacteriaceae Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TBA
SolGent
ELITechGroup
ALIFAX
BioMérieux
Segment by Type
Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
Other Types
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Carbapenem-resistant Enterobacteriaceae Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii.
The global Carbapenem-resistant Enterobacteriaceae Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Carbapenem-resistant Enterobacteriaceae Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Carbapenem-resistant Enterobacteriaceae Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Carbapenem-resistant Enterobacteriaceae Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Carbapenem-resistant Enterobacteriaceae Testing include TBA, SolGent, ELITechGroup, ALIFAX and BioMérieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carbapenem-resistant Enterobacteriaceae Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem-resistant Enterobacteriaceae Testing.
Report Scope
The Carbapenem-resistant Enterobacteriaceae Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carbapenem-resistant Enterobacteriaceae Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbapenem-resistant Enterobacteriaceae Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TBA
SolGent
ELITechGroup
ALIFAX
BioMérieux
Segment by Type
Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
Other Types
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Carbapenem-resistant Enterobacteriaceae Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
1.2.3 Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
1.2.4 Other Types
1.3 Market by Application
1.3.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Perspective (2019-2030)
2.2 Carbapenem-resistant Enterobacteriaceae Testing Growth Trends by Region
2.2.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Carbapenem-resistant Enterobacteriaceae Testing Historic Market Size by Region (2019-2024)
2.2.3 Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Region (2025-2030)
2.3 Carbapenem-resistant Enterobacteriaceae Testing Market Dynamics
2.3.1 Carbapenem-resistant Enterobacteriaceae Testing Industry Trends
2.3.2 Carbapenem-resistant Enterobacteriaceae Testing Market Drivers
2.3.3 Carbapenem-resistant Enterobacteriaceae Testing Market Challenges
2.3.4 Carbapenem-resistant Enterobacteriaceae Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Revenue
3.1.1 Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Revenue (2019-2024)
3.1.2 Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Players (2019-2024)
3.2 Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Carbapenem-resistant Enterobacteriaceae Testing Revenue
3.4 Global Carbapenem-resistant Enterobacteriaceae Testing Market Concentration Ratio
3.4.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carbapenem-resistant Enterobacteriaceae Testing Revenue in 2023
3.5 Carbapenem-resistant Enterobacteriaceae Testing Key Players Head office and Area Served
3.6 Key Players Carbapenem-resistant Enterobacteriaceae Testing Product Solution and Service
3.7 Date of Enter into Carbapenem-resistant Enterobacteriaceae Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Carbapenem-resistant Enterobacteriaceae Testing Breakdown Data by Type
4.1 Global Carbapenem-resistant Enterobacteriaceae Testing Historic Market Size by Type (2019-2024)
4.2 Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Type (2025-2030)
5 Carbapenem-resistant Enterobacteriaceae Testing Breakdown Data by Application
5.1 Global Carbapenem-resistant Enterobacteriaceae Testing Historic Market Size by Application (2019-2024)
5.2 Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size (2019-2030)
6.2 North America Carbapenem-resistant Enterobacteriaceae Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2019-2024)
6.4 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size (2019-2030)
7.2 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2019-2024)
7.4 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size (2019-2030)
8.2 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size (2019-2030)
9.2 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2019-2024)
9.4 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size (2019-2030)
10.2 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 TBA
11.1.1 TBA Company Detail
11.1.2 TBA Business Overview
11.1.3 TBA Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.1.4 TBA Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024)
11.1.5 TBA Recent Development
11.2 SolGent
11.2.1 SolGent Company Detail
11.2.2 SolGent Business Overview
11.2.3 SolGent Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.2.4 SolGent Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024)
11.2.5 SolGent Recent Development
11.3 ELITechGroup
11.3.1 ELITechGroup Company Detail
11.3.2 ELITechGroup Business Overview
11.3.3 ELITechGroup Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.3.4 ELITechGroup Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024)
11.3.5 ELITechGroup Recent Development
11.4 ALIFAX
11.4.1 ALIFAX Company Detail
11.4.2 ALIFAX Business Overview
11.4.3 ALIFAX Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.4.4 ALIFAX Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024)
11.4.5 ALIFAX Recent Development
11.5 BioMérieux
11.5.1 BioMérieux Company Detail
11.5.2 BioMérieux Business Overview
11.5.3 BioMérieux Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.5.4 BioMérieux Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024)
11.5.5 BioMérieux Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
Table 3. Key Players of Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
Table 4. Key Players of Other Types
Table 5. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Region (2019-2024)
Table 9. Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Region (2025-2030)
Table 11. Carbapenem-resistant Enterobacteriaceae Testing Market Trends
Table 12. Carbapenem-resistant Enterobacteriaceae Testing Market Drivers
Table 13. Carbapenem-resistant Enterobacteriaceae Testing Market Challenges
Table 14. Carbapenem-resistant Enterobacteriaceae Testing Market Restraints
Table 15. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Players (2019-2024)
Table 17. Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-resistant Enterobacteriaceae Testing as of 2023)
Table 18. Ranking of Global Top Carbapenem-resistant Enterobacteriaceae Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Carbapenem-resistant Enterobacteriaceae Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Carbapenem-resistant Enterobacteriaceae Testing Product Solution and Service
Table 22. Date of Enter into Carbapenem-resistant Enterobacteriaceae Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Application (2019-2024)
Table 30. Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Application (2025-2030)
Table 32. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. TBA Company Detail
Table 48. TBA Business Overview
Table 49. TBA Carbapenem-resistant Enterobacteriaceae Testing Product
Table 50. TBA Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024) & (US$ Million)
Table 51. TBA Recent Development
Table 52. SolGent Company Detail
Table 53. SolGent Business Overview
Table 54. SolGent Carbapenem-resistant Enterobacteriaceae Testing Product
Table 55. SolGent Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024) & (US$ Million)
Table 56. SolGent Recent Development
Table 57. ELITechGroup Company Detail
Table 58. ELITechGroup Business Overview
Table 59. ELITechGroup Carbapenem-resistant Enterobacteriaceae Testing Product
Table 60. ELITechGroup Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024) & (US$ Million)
Table 61. ELITechGroup Recent Development
Table 62. ALIFAX Company Detail
Table 63. ALIFAX Business Overview
Table 64. ALIFAX Carbapenem-resistant Enterobacteriaceae Testing Product
Table 65. ALIFAX Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024) & (US$ Million)
Table 66. ALIFAX Recent Development
Table 67. BioMérieux Company Detail
Table 68. BioMérieux Business Overview
Table 69. BioMérieux Carbapenem-resistant Enterobacteriaceae Testing Product
Table 70. BioMérieux Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024) & (US$ Million)
Table 71. BioMérieux Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Type: 2023 VS 2030
Figure 3. Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing Features
Figure 4. Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing Features
Figure 5. Other Types Features
Figure 6. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Carbapenem-resistant Enterobacteriaceae Testing Report Years Considered
Figure 12. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Region: 2023 VS 2030
Figure 15. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Players in 2023
Figure 16. Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-resistant Enterobacteriaceae Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Carbapenem-resistant Enterobacteriaceae Testing Revenue in 2023
Figure 18. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2019-2030)
Figure 20. United States Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2019-2030)
Figure 24. Germany Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Share by Region (2019-2030)
Figure 32. China Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2019-2030)
Figure 40. Mexico Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2019-2030)
Figure 44. Turkey Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. TBA Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024)
Figure 47. SolGent Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024)
Figure 48. ELITechGroup Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024)
Figure 49. ALIFAX Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024)
Figure 50. BioMérieux Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
